Research & Development

Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

Charles River Laboratories International, Inc. and Valence Discovery announced the formation of a strategic partnership to provide clients access to Valence’s artificial intelligence platform...

Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine

News

02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK MHRA has issued an advisory...

Cancer Treatment Can Be Cloned For COVID-19

News

As per the recent international study by the scientists from Italy & Australia, Beta-blockers have it in them to be a potential treatment for...

Antengene signs MoU with WuXi Biologics to advance development of innovative oncology medicines

Drug Development

Antengene Corporation, a leading innovative biopharmaceutical company, and WuXi Biologics (WuXi Bio) announced that they have signed a strategic cooperation Memorandum of Understanding (MoU)...

Eisai Enters Joint Development Agreement for COVID-19 Therapeutics

Drug Development

Eisai Co. has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global Health and Medicine, Nagasaki...

POINT Biopharma to Launch First US Manufacturing Facility in Indiana

Americas

POINT Biopharma (POINT) announced plans today to establish its first U.S. manufacturing facility in Indianapolis. “Indiana has established itself as a global leader in...

BMS ristol Myers Squibb Research at ASCO Demonstrates Diverse Approaches in Treating Cancer to Improve Outcomes for Patients

Drug Development

Bristol Myers Squibb announced the presentation of data across its portfolio, aimed at addressing solid tumor and hematologic malignancies in 28 types of cancer,...

Subscribe Our Newsletter

White Papers

Whitepapers

Research & Development

About us

Resources

Advertise

Subscribe